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Abstract
In sub-Saharan Africa, invasive non-Typhoid Salmonella (NTS) is a common and often fatal
complication of Plasmodium falciparum infection. Induction of heme oxygenase-1 (HO-1)
mediates tolerance to the cytotoxic effects of heme during malarial hemolysis but might impair
resistance to NTS by limiting production of bactericidal reactive oxygen species. We show that
co-infection of mice with Plasmodium yoelii 17XNL (Py17XNL) and S. typhimurium causes
acute, fatal bacteremia with increased bacterial load; features reproduced by phenylhydrazine
hemolysis or hemin administration. S. typhimurium localized predominantly in granulocytes.
Py17XNL, phenylhydrazine and hemin caused premature mobilization of granulocytes from bone
marrow with a quantitative defect in the oxidative burst. Inhibition of HO by tin protoporphyrin
abrogated the impairment of resistance to S. typhimurium by hemolysis. Thus a mechanism of
tolerance to one infection, malaria, impairs resistance to another, NTS. Furthermore, HO inhibitors
may be useful adjunctive therapy for NTS infection in the context of hemolysis.
NTS bacteremia is the most common cause of community acquired bacteremia in many
parts of sub-Saharan Africa1 and NTS co-infection has been associated with increased
malaria mortality2. The association of NTS infection with hemolysis is well established in
humans with malaria (especially severe malarial anemia)3-4 and sickle cell disease5, and in
mice with hemolysis due to rodent malaria infection6-8, treatment with phenylhydrazine or
anti-erythrocyte antibodies, or red blood cell enzyme defects 9-11. It has been assumed that
hemolysis-induced macrophage dysfunction was responsible for this phenomenon, although
there is no direct evidence that macrophages are the primary refuge of NTS in vivo in the
context of hemolysis7-8,10.
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Hemolysis results in liberation of heme, leading to expression of the inducible isoform of
heme oxygenase-1 (HO-1)12 which degrades heme to biliverdin, carbon monoxide and
iron13. Heme is pro-oxidant, induces neutrophil migration and activates the neutrophil
oxidative burst14-16 but HO-1 (and its products) play an essential cytoprotective role
(reviewed in 17) - dramatically demonstrated by the severe susceptibility to oxidative stress
in mice and humans with HO-1 deficiency18-20. HO-1 induction has been shown to protect
against infectious, inflammatory and hypoxic-ischemic insults in mice (reviewed in 21) and
has been linked to modulation of malarial pathogenesis22 and sickle cell disease23. Recently,
in mice, induction of HO-1 has been proposed as a tolerance mechanism in severe
malaria24-26 and polymicrobial sepsis27: HO-1 reduces heme-mediated tissue damage and
enhances survival without reducing pathogen load. An important cytoprotective effect of
HO-1, and thus a likely explanation for its ability to confer tolerance, is its ability to limit
the production of damaging reactive oxygen species (ROS, reviewed in 17). However, ROS
are important for resistance to certain pathogens, including Salmonella28, and this raises the
intriguing possibility that tolerance of one pathogen may sometimes come at the price of
loss of resistance to another. We hypothesized that liberation of heme by intravascular
hemolysis may lead to HO-1 induction and impairment of resistance to NTS, with increased
bacterial replication and mortality.
Results
Hemolysis and heme cause impaired resistance to S. typhimurium bacteremia
To determine whether heme liberated by hemolysis impairs resistance to NTS infection, we
compared survival and bacterial loads following intraperitoneal infection with green
fluorescent protein (GFP)-expressing S. enterica serovar Typhimurium 12023 (hereafter
referred to as S. typhimurium) in C57BL/6 mice with or without preceding Plasmodium
yoelii 17XNL (Py17XNL) co-infection, phenylhydrazine (PHZ) or hemin treatment.
Py17XNL infection of C57BL/6 mice causes a self-resolving infection; parasitemia peaks at
20-30% and is accompanied by progressive hemolytic anemia (Fig. 1a). By contrast, PHZ
treatment causes acute hemolysis (Fig. 1b). In both cases, plasma heme concentrations are
markedly increased and similar to concentrations achieved 12 hours after injection of hemin
(Fig. 1c), but without depletion of haptoglobin or hemopexin (Supplementary Fig. 1a,b).
Survival of Salmonella-infected mice was dramatically shortened by prior Py17XNL
infection, PHZ or hemin treatment (Fig. 1d), and was significantly shorter in PHZ- and
hemin-treated mice (16 h) than in Py17XNL co-infected mice (18 h) (P < 0.01, Log Rank
Mantel Cox test). PHZ, hemin and Py17XNL did not cause any mortality in the absence of
S. typhimurium infection.
Decreased survival of malaria-infected, PHZ- or hemin-treated mice after S. typhimurium
infection was accompanied by increased bacterial loads in whole blood, spleen, liver and
bone marrow (Fig. 1e) and bacteremia was much more pronounced: immediately before
death (i.e. 16-18 h after infection in Py17XNL-infected, PHZ- or hemin-treated mice and 72
h after infection in control mice) bacterial loads in the blood of infected or treated mice were
proportionately higher, and bacterial loads in liver and spleen proportionately lower (Fig.
1e) than in control mice (Fig. 1f).
Salmonella localize in granulocytes following hemolysis and hemin treatment
By flow cytometry, we identified GFP+ (Salmonella-containing) cells in blood, spleen and
bone marrow. In the blood of Py17NXL-infected mice, and of PHZ- or hemin-treated mice,
just before death, Salmonellae were found predominantly in Gr-1Hi cells (Fig. 2a), and were
enriched in this cell population compared to control (PBS-treated) mice (Fig. 2b). The
proportion of all Gr-1Hi cells in blood, spleen and bone marrow which were GFP+ (Fig. 2c)
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correlated with the bacterial load determined by culture (Fig. 1e,f). The Gr-1Hi cells were
identified as granulocytes (Ly6G+ F4/80−CD115−; Supplementary Fig. 2a,b). Almost all
GFP+ cells were CD115− (Fig. 2d); moreover, Salmonella infection caused an increase in
the proportion of Gr-1LoCD115− blood leukocytes (Fig. 2e), suggesting that immature
granulocytes are mobilized from the bone marrow to the peripheral blood during infection29.
In support of this, blood films from Py17XNL-infected and PHZ or hemin-treated mice 18 h
after Salmonella infection (Fig. 2f) revealed numerous neutrophils containing S.
typhimurium and many of these neutrophils had immature nuclear morphology. In contrast,
neutrophils from PBS-treated mice displayed mature nuclear morphology and did not
contain Salmonella.
The accumulation of GFP+ bacteria in granulocytes was not simply due to failure of
bacterial uptake by monocytes and macrophages, since the proportions of GFP+ cells in the
spleen which were either monocytes or macrophages (F4/80LoCD11bHi and
F4/80HiCD11bLo respectively) did not differ between Py17XNL infected- or PHZ or hemin-
treated mice and those treated with PBS alone (Supplementary Fig. 2c).
Py17XNL inhibits granulocyte oxidative burst and Salmonella killing
Since there is no obvious defect in uptake of S. typhimurium by macrophages and
monocytes following hemolysis or hemin treatment, accumulation of S. typhimurium in
blood granulocytes may result from impaired bacterial killing or a more permissive
intracellular environment for bacterial replication. To investigate these possibilities we
isolated CD11b+ cells from blood of Py17XNL-infected and uninfected mice and compared
their ability to phagocytose and kill S. typhimurium. Neither flow cytometric analysis of
GFP+ cells nor quantitative culture (in a gentamicin protection assay) revealed any
differences in rates of phagocytosis of S. typhimurium between neutrophils or monocytes or
between cells from malaria-infected or uninfected mice (Fig. 3a,b); the intracellular location
of GFP+ bacteria was confirmed by confocal microscopy (Supplementary Fig. 3a,b).
However, when cells were lysed after 2 h in the gentamicin protection assay and live
bacteria enumerated by culture, live bacterial recovery from cells from Py17XNL-infected
mice was significantly higher than from control mice (Fig. 3b) indicating significant
impairment of intracellular killing of S. typhimurium by cells from Py17XNL-infected mice.
Since HO-1 reduces the production of ROS30-33, and since phagocyte NADPH oxidase is
essential for early resistance to S. typhimurium28, we investigated whether Py17XNL
infection impaired the granulocyte oxidative burst. Using oxidation of dihydrorhodamine to
its fluorescent derivative rhodamine to assess oxidative burst34, we observed progressive
suppression of the PMA-induced oxidative burst of blood granulocytes during infection
(Fig. 3c). Granulocytes were not simply refractory to PMA stimulation since PMA-induced
degranulation (assessed by surface CD11b expression35) was actually enhanced 14 and 21
days after malaria infection (Fig. 3d). However, blood granulocytes isolated 24 h after PHZ
or hemin treatment did not differ from those of control mice in oxidative burst capacity,
degranulation, ex vivo phagocytosis or killing of S. typhimurium (Fig. 3c,d and
Supplementary Fig. 3c,d).
Hemolysis induces dysfunctional granulocyte mobilization
Accumulation of heme following PHZ-hemolysis or hemin administration is faster than
during Py17XNL infection. Heme directly induces neutrophil migration and ROS
production16 whilst subsequent HO-1 induction in myeloid cells suppresses neutrophil
maturation and ROS production30,33. Since HO-1 is induced in bone marrow by
hemolysis26, we wondered whether the chronic hemolysis associated with Py17XNL
infection might induce HO-1 in immature bone marrow myeloid cells, suppress their
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oxidative burst capacity as they mature, and allow gradual accumulation of dysfunctional
cells in the circulation, whereas acute hemolysis (induced by PHZ) may both activate the
oxidative burst of circulating granulocytes and mobilize functionally immature bone marrow
granulocytes, resulting in heterogeneous oxidative burst activity of blood granulocytes (as
suggested by Fig. 3c).
In mice, granulocyte maturation in bone marrow is characterized by increasing expression of
Gr-129. Gr-1Hi cells are mature neutrophils and Gr-1Lo cells are immature granulocytes and
granulocyte progenitors; the Gr-1Int (intermediate) compartment contains a mixture of cell
types. Generation of an oxidative burst is restricted to a functionally mature subpopulation
of cells36 in the Gr-1Hi, and to a lesser extent Gr-1Int, compartment (Supplementary Fig. 4).
Hemin and PHZ treatment, and Py17XNL infection, all caused striking depletion of Gr-1Hi
cells from bone marrow (Fig. 3e and Supplementary Fig. 5). For PHZ and hemin treatment,
loss of Gr-1Hi cells from bone marrow was accompanied by an increase in granulocytes in
peripheral blood (Supplementary Fig. 5), confirming the effect of free heme in mobilization
of granulocytes from bone marow to the periphery. Although the proportion of circulating
granulocytes did not increase during Py17XNL infection, granulocyte mobilization may be
obscured by an overall increase in leukocyte count or granulocyte redistribution (eg. from
blood to the spleen)37. S. typhimurium infection caused granulocyte mobilization in PBS-
treated mice, and markedly exacerbated the granulocyte mobilization in Py17XNL-infected
and PHZ- or hemin-treated mice (Fig. 3e and Supplementary Fig. 5), consistent with the
presence of immature granulocytes in blood (Fig 2e). To confirm that hemolysis and
bacterial challenge did indeed result in granulocytes with reduced oxidative burst activity
entering the circulation, the oxidative burst of circulating granulocytes was assessed. Eight
hours after S. typhimurium infection the oxidative burst response to PMA was enhanced in
PBS-treated mice (presumably due to priming38) but oxidative burst capacity was
dramatically reduced in PHZ treated mice (Fig. 3f).
Finally, we investigated whether maturation of the oxidative burst in bone marrow
granulocytes was also impaired, as predicted. On day 14 of Py17XNL infection, and 18 h
after PHZ or hemin treatment, there was a clear quantitative defect in the PMA-induced
oxidative burst of Gr-1Hi cells (Fig. 3g), evident as an increase in the proportion of cells
with low oxidative burst capacity (Fig. 3h) and a decrease in the proportion of cells with
high burst capacity, compared to the PBS control.
Together, these data indicate that intravascular heme (released during hemolysis) mobilizes
granulocytes from bone marrow and simultaneously impairs development of their oxidative
burst. Thus, granulocytes entering the circulation in response to subsequent infection are
able to phagocytose S. typhimurium but, due to reduced oxidative burst capacity, fail to kill
them, providing instead a niche for bacterial replication and dissemination.
HO-1 is induced in immature bone marrow myeloid cells
Since the cytoprotective effects of HO-1, and of the heme degradation product, carbon
monoxide, have been attributed to inhibition of ROS production17,39, we wondered whether
suppression of granulocyte oxidative burst correlated with HO-1 induction during
granulopoiesis. As expected25,40, PHZ treatment and Py17XNL infection led to systemic
induction of HO-1 (Supplementary Fig. 6a-c). HO-1 was consistently induced in peripheral
blood monocytes by Py17XNL, PHZ and hemin, but only (to a modest extent) by hemin in
circulating granulocytes and by Py17XNL in the non-myeloid population (Supplementary
Fig. 6d).
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In bone marrow of untreated-uninfected mice, HO-1 is expressed mainly in F4/80+ cells
(Fig. 4a), presumably macrophages and monocytes. However, in hemin and PHZ-treated
mice there was a significant increase in the proportion of HO-1+ bone marrow cells,
especially in the Gr-1Lo/−F4/80− compartment (Fig. 4a,b). There was a small but significant
increase in the proportion of HO-1+ Gr-1Lo F4/80− cells in Py17XNL-infected mice (Fig.
4b) but no overall increase in bone marrow HO-1+ cells, likely due to mobilization of
F4/80+ cells from bone marrow to blood and spleen37,41 (Supplementary Fig. 7). The
Gr-1lo/−F4/80− compartment contains myeloid progenitors and immature myeloid cells.
Since surface markers to positively identify murine myeloblasts and promyelocytes have not
yet been defined, we assessed HO-1 expression in the granulocyte macrophage progenitor
(GMP) population which is proximal to the myeloblast in the myeloid differentiation
pathway42. Py17XNL, PHZ and hemin all caused significant induction of HO-1 even at this
very early stage of development (Fig. 4c). Thus, malaria infection, hemolysis and hemin
treatment all induce HO-1 expression in the earliest stages of granulocyte development and
thereby impair subsequent functional maturation of these cells.
Impaired resistance to Salmonella is abrogated by HO inhibition
To test the hypothesis that HO-1 impairs resistance of Py17XNL-infected mice to S.
typhimurium bacteremia, we pre-treated mice with the competitive HO inhibitor, tin
protoporphyrin IX (SnPP). Treatment of Py17XNL-infected mice with SnPP for 48 h prior
to S. typhimurium infection reduced bacterial loads in blood, spleen and liver to levels not
significantly different from those in PBS treated mice (Fig. 5a). SnPP treatment had no
effect on bacterial load in mice without Py17XNL infection (Fig. 5a), or on parasitemia in
Py17XNL-infected mice (Fig. 5b) but very effectively prevented accumulation of GFP+ S.
typhimurium within granulocytes in Py17XNL-infected mice (Fig. 5c,d). SnPP also partially
restored resistance to S. typhimurium when administered 2 h prior to PHZ treatment (Fig.
5a,c,d) and prolonged the survival of Py17XNL or PHZ-treated mice after S. typhimurium
infection (Fig. 5e). Cobalt protoporphyrin (CoPP), which induces HO-1 in the absence of
hemolysis or free heme43, did not impair resistance to S. typhimurium 16 h post infection
(Fig. 5a). Thus, both heme and HO-1 are necessary for impairment of resistance to S.
typhimurium caused by Py17XNL or PHZ hemolysis, and inhibition of HO abrogates this
effect. Inhibition of HO by SnPP did not restore the oxidative burst of Gr-1Hi bone marrow
granulocytes in Py17XNL-infected or PHZ-treated mice (Fig. 5f), presumably due to
enhanced mobilization of mature Gr-1Hi cells (Fig. 5g) as a result of greater heme
accumulation (Fig. 3e, Supplementary Fig. 5). However, SnPP did reverse the accumulation
of granulocytes with low level oxidative burst activity in the bone marrow of Py17XNL-
infected and PHZ-treated mice (Fig. 5h), indicating that inhibition of HO restores normal
development of the oxidative burst in maturing bone marrow granulocytes.
Discussion
Understanding the etiology of NTS septicemia in individuals with malaria and other
hemolytic disorders may lead to new strategies to reduce morbidity and mortality. To reflect
the clinical association between NTS septicemia and severe malarial anemia3-4 we have
used a model in which malaria infection causes progressive hemolysis, eventually resulting
in severe (but non-lethal) anemia, to assess the impact of S. typhimurium co-infection on
disease. We demonstrate that loss of resistance to S. typhimurium requires hemolytic release
of cell-free heme and subsequent induction of HO-1, and that inhibition of HO-1 reverses
this susceptibility to NTS. Thus, although HO-1 is essential for tolerance to the cytotoxic
effects of free heme, reducing disease severity without altering pathogen load24-27, HO-1-
mediated tolerance to malaria simultaneously impairs resistance to S. typhimurium.
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We propose (Fig 6) that during acute hemolysis, heme triggers immediate mobilisation of
granulocytes from bone marrow to blood and generation of ROS16, whilst simultaneously
inducing HO-1 in immature myeloid cells and thereby reducing their subsequent oxidative
burst capacity30,33, perhaps by limiting the availability of heme for incorporation into
NADPH oxidase44. This results in mobilization of a heterogeneous population of
granulocytes with varying levels of oxidative burst capacity. During malaria infection
however, progressive hemolysis leads to sustained release of free heme which both impairs
maturation of oxidative burst capacity of granulocytes in the bone marrow and mobilizes
functionally immature granulocytes from bone marrow into the peripheral circulation.
Accumulation in peripheral blood of functionally-impaired granulocytes, which phagocytose
but are unable to kill bacteria, provides a new niche for bacterial replication and
dissemination. In this scenario, HO-1 contributes to impaired resistance to NTS but heme
also plays a direct role – either in granulocyte mobilization16 or as a substrate for HO-1. The
heme degradation products carbon monoxide, biliverdin and iron may further impair
resistance to NTS by reducing production of ROS21 or facilitating bacterial replication45. In
contrast, non-heme induction of HO-1 (e.g. by CoPP) may limit available iron for bacterial
replication and protect phagocytic cells from apoptosis45-46.
Our observation that hemolysis specifically suppresses the oxidative burst capacity of
neutrophils offers a plausible explanation for the particular susceptibility to NTS bacteremia
in individuals with hemolysis. Salmonella have evolved to survive and replicate inside
mononuclear phagocytes47; hemolysis provides an additional niche for sustained bacterial
replication in circulating neutrophils. Our results are also consistent with studies of the
cytoprotective role of HO-1 in mice; indeed limitation of the granulocyte oxidative burst
could be an important adaptive mechanism to reduce self-damage by ROS during hemolysis
and to prevent tissue injury associated with release of heme.
Very few tolerance mechanisms have been clearly identified48, despite recent interest in
their therapeutic potential 49. In mice, HO-1 confers tolerance to blood stage malaria24-25
but simultaneously diminishes resistance to malaria parasites developing the liver50.
However, in Drosophila, infection-induced anorexia increases tolerance against S.
typhimurium but reduces resistance against Listeria monocytogenes 51, indicating that
resistance and tolerance mechanisms can be highly pathogen specific and that a mechanism
of tolerance to one pathogen can diminish resistance to another. Although it is well
recognized that co-infection with different pathogens can enhance disease severity, and in
some cases molecular mechanisms have been elucidated52, this study provides the first
direct evidence in a mammal of tolerance to one pathogen impairing resistance to another.
To conclude, our findings have a number of important implications. First, they provide an
explanation for the susceptibility to NTS bacteremia in malaria and sickle cell disease
patients. Second, they imply that tolerance and resistance mechanisms identified from
studies of single pathogens may not easily translate to the “real world” where people are
simultaneously exposed to multiple pathogens. Specifically, the concept that the
cytoprotective effects of HO-1 may be harnessed by administering its products
therapeutically in humans without adversely affecting host defence against infection53-54
may not be valid. Third, we have identified a potential adjunct therapy (SnPP) which might
enhance resistance to NTS in patients with hemolytic diseases. SnPP has been used
experimentally to prevent severe jaundice55 but optimization of treatment would be crucial
to avoid impairment of tolerance to heme. The experimental system described here may be a
good starting point to assess and optimize such treatments.
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Appendix
Methods
Detailed methods are provided as Supplementary Methods.
We stored aliquots from a single broth culture of Salmonella enterica serovar Typhimurium
12023 (S. typhimurium), constitutively expressing GFP, in 10% glycerol at −80 °C. For in
vitro experiments we opsonized Salmonella in 20% normal mouse serum at 37°C for 30 min
prior to inoculation. For quantitation of bacterial loads, we plated 10 fold-dilutions of lysed
organ homogenates and whole blood onto LB agar and incubated for 18 hours before
counting the number of colony forming units (CFUs).
Animals
Animal experimentation conformed with UK Home Office Regulations and was approved
by Institutional ethical review (London School of Hygiene and Tropical Medicine). We
obtained female, 6-10 week old C57BL/6 mice from Harlan and Charles River, UK, and
infected them with Plasmodium yoelii 17X non-Lethal (Py17XNL) by i.p. injection of 105
parasitised red blood cells (pRBCs). We determined parasitemia by examination of Giemsa-
stained thin blood smears. We determined erythrocyte counts using a Z2 Coulter particle
counter. We induced acute hemolysis by subcutaneous injection of phenylhydrazine (125 μg
g−1). We administered hemin by i.p. injection (50 μmol kg−1 per dose) in two doses 12
hours apart. We initiated Salmonella infections by i.p. inoculation of 105 CFU of S.
typhimurium on day 15 of Py17XNL infection or 6 h after PHZ or first dose of hemin
treatment. We administered SnPP (40 μmol kg−1 per dose) by i.p. injection 48, 24 and 8 h
before S. typhimurium infection of Py17XNL infected mice, 2 h before PHZ treatment, or 8
h before S. typhimurium alone. We administered CoPP (10mg kg−1 body weight) i.p. 6 h
before S. typhimurium infection. We monitored S. typhimurium infected mice 6 hourly until
they displayed signs of illness (clinical stage 2, see Supplementary Methods) and then every
1-2 h until they reached the humane endpoint (clinical stage 4), at which point they were
euthanized. The time of euthanasia was used for survival analysis.
Flow cytometry
Antibodies used are shown in Supplementary Methods. We performed intracellular staining
for HO-1 based on the method of Ewing et al 56.
Microscopy
Chamber slides were protected from light and air-dried for 2 h before nuclear staining and
mounting with DAPI dissolved in confocal matrix. To determine whether bacteria were
intracellular or adherent to the cell surface, we assessed cells with overlapping GFP+ S.
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typhimurium by 0.5 μm interval Z-stack imaging. For light microscopy, we fixed thin blood
films with methanol and air dried before staining with May-Grünwald Giemsa stain).
Salmonella phagocytosis and killing assays
We assessed ex-vivo phagocytosis and killing of S. typhimurium in a gentamicin protection
assay and quantified by flow cytometry (staining with APC-conjugated antibody against
Gr-1 and PE-Cy7-conjugated antibody against CD11b), confocal microscopy and bacterial
culture. We seeded isolated CD11b+ cells at 1×105 per well in flat bottomed 96-well plates
or at 2×105 per well in 8-well chamber slides and incubated at 37°C and 5% CO2 for 20 min
prior to addition of S. typhimurium at a multiplicity of infection (MOI) of 10 S.
typhimurium: 1 CD11b+ cell. We determined phagocytosis at 45 min after infection and
killing at 2 h after infection.
Oxidative burst and degranulation assay
We assessed neutrophil oxidative burst using a modification of the flow cytometric assay
described by Richardson et al.34 in which dihydrorhodamine 123 is converted to rhodamine.
We measured neutrophil degranulation by the percentage increase in the median
fluorescence intensity of surface CD11b expression in stimulated versus unstimulated
samples.
Measurement of heme and hemoglobin
We determined concentrations of hemin and hemoglobin using Quantichrom Heme and
Hemoglobin assay kits. We quantified protein bound plasma heme using the
spectrophotometric method of Shinowara and Waters57 and the concentration of plasma
hemoglobin using the method of Khan et al.58.
Hmox1 expression and HO activity assays
We determined Hmox1 mRNA expression in liver by quantitative RT-PCR. We
standardized cDNA expression for each sample using the housekeeping genes Gapdh and
Tbp and calculated expression as relative fold change compared to healthy control samples.
We measured HO activity in whole liver homogenates after RBC lysis, using the method of
Foresti et al. 59. We measured plasma HO-1 by ELISA using a HO-1 Immunoset.
Statistical analysis
We performed statistical analysis using Graph Pad Prism 5 software. We used an alpha
value of 0.05 for all pre-planned statistical analyses. We used the Log Rank Mantel Cox test
for survival analysis. We analyzed continuous data which were approximately normally
distributed using two-sided unpaired or paired student’s t-test for pairwise comparisons, or
one-way ANOVA with post-hoc testing using Dunnett’s multiple comparison test for
comparison with the control group, Tukey’s multiple comparison test for comparison
between multiple groups, and Bonferroni’s multiple comparison test for comparison
between two or more selected pairs. We log10-transformed all data relating to bacterial loads
prior to analysis. We compared proportions between groups using Fisher’s exact test.
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Figure 1. Hemolysis and heme are associated with impaired resistance to S. typhimurium
(a) Erythrocyte count and parasitemia of mice infected with Plasmodium yoelii 17XNL
(Py17XNL). Data representative of 7 independent experiments (mean ± s.d. of 5-25 mice
per time point). (b) Erythrocyte count before- and 18 h after - subcutaneous injection of
phenylhydrazine (PHZ). Data representative of 3 independent experiments (mean ± s.d. of 5
mice). (c) Plasma heme levels during Py17XNL infection and 15 h after PHZ- or 12 h after
hemin treatment. Data representative of at least 2 independent experiments (mean ± s.d. of
4-5 mice) per condition and time point. (d) Survival (time until reaching humane endpoint)
of mice infected with S. typhimurium on day 15 of Py17XNL or 6 h after PHZ, first dose of
hemin or PBS treatment. Data representative of ≥4 independent experiments (mean ± s.d. of
4-5 mice) per condition. (e) S. typhimurium bacterial loads in whole blood, spleen, liver, and
bone marrow, 18 h post-infection for PBS-treated controls, and at humane endpoint for other
conditions. (f) S. typhimurium bacterial loads in whole blood, spleen, and liver at 18 h or 72
h (humane end-point) post-infection for PBS-treated mice. (e,f). Data representative of ≥2
independent experiments (mean ± s.d. of 4-5 mice) per condition. Significance determined
by two-tailed paired Student’s t-test (b), one-way ANOVA with Dunnett’s multiple
comparison test (c,e,f), or Log Rank Mantel Cox test (d). *P < 0.05,**P < 0.01, ***P <
0.001.
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Figure 2. S. typhimurium localize in granulocytes following hemolysis and hemin treatment
(a) Representative flow cytometry plots of blood leukocytes collected from GFP-S.
typhimurium- infected (lower panels) and uninfected (upper panels) mice at the humane
endpoint or indicated timepoint. Data representative of ≥4 independent experiments (n = 4-5
mice) per condition. (b) Proportion of all GFP+ blood leukocytes with high levels of Gr-1
expression (PBS 18 h not shown due to very low absolute numbers of GFP+ cells). (c)
Infected mature granulocytes (GFP+Gr-1Hi) as a proportion of all Gr-1Hi cells in blood,
spleen and bone marrow. (d) Proportion of all GFP+ cells in blood that are CD115−. (b-d)
Data representative of ≥2 independent experiments (mean ± s.d. of 4-5 mice) per condition.
(e) Representative flow cytometry analysis defining immature granulocytes as
Gr-1LoCD115− (upper panel) and quantification of the proportion of blood leukocytes that
are Gr-1LoCD115− (lower panel). Data combined from 2 independent experiments (mean ±
s.d. of 4-9 mice) per condition. (f) Light microscope images of neutrophils from May-
Grünwald Giemsa-stained thin blood films of S. typhimurium infected mice, 18 h after
infection in PBS treated mice, or at the humane endpoint (Py17XNL infected and PHZ or
hemin treated mice). Images are representative of neutrophils containing bacteria, except for
PBS treated mice where no bacteria were seen, from 2 independent experiments with 3-5
mice per condition. Scale bar 10 μm. Significance determined by one-way ANOVA with
Dunnett’s multiple comparison test. *P < 0.05,**P < 0.01, ***P < 0.001.
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Figure 3. Hemolysis and heme cause dysfunctional granulocyte mobilization
In vitro phagocytosis (a,b) and killing (b) of S. typhimurium by CD11b+ cells from blood of
control and Py17XNL infected (day 15) mice. (a) Phagocytosis: percentage of granulocytes
(Gran) and monocytes (Mono) which were GFP+. (b) Phagocytosis (45 min) and killing (2
h) of S. typhimurium assessed by quantitative culture. Data representative of 2 independent
experiments (mean ± s.d. of 3-5 mice per condition). (c,d) PMA-stimulated oxidative burst
(c) and degranulation (d) of granulocytes in whole blood from control, Py17XNL-infected
and PHZ- or hemin-treated (24 h after first treatment) mice, relative to mean of PBS
controls. Representative of ≥2 independent experiments (mean ± s.d. of 3-8 mice) per
condition and timepoint. (e) Flow cytometry analysis of Gr-1 expression by bone marrow
cells in uninfected mice (upper panels) or 16 h after S. typhimurium infection (lower
panels). Representative of ≥4 independent experiments per condition. (f) PMA-stimulated
oxidative burst of whole blood granulocytes 14 h after PHZ or PBS treatment (6 h after S.
typhimurium infection). Rhodamine fluorescence for unstimulated-uninfected (grey filled),
unstimulated-infected (heavy line), PMA-stimulated-uninfected (light line) and PMA-
stimulated-infected (dashed line), PBS- and PHZ-treated mice (left panels); quantitative data
for PMA-stimulated blood (right panel). Representative of 2 independent experiments (mean
± s.d. of 4 mice per condition). (g) PMA-stimulated oxidative burst of Gr-1 Hi bone marrow
granulocytes from control, day 14 Py17XNL, and hemin and PHZ treated mice.
Representative of ≥3 independent experiments (mean ± s.d. of 3-5 mice) per condition. (h)
Proportion of Gr-1Hi bone marrow cells making low level oxidative burst response to PMA.
Total, low and high level oxidative burst populations (left panels; unstimulated control in
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grey) and quantitative data (right panel). Representative of ≥3 independent experiments
(mean ± s.d. of 3-5 mice) per condition. Significance determined by two-tailed Student’s t-
test (a,b,f) or one-way ANOVA with post-hoc comparison with control using Dunnett’s
multiple comparison test (c,d,f,g,h). *P < 0.05,**P < 0.01, ***P < 0.001.
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Figure 4. HO-1 induction in bone marrow
(a) Representative flow cytometry plots identifying bone marrow cells expressing HO-1,
which were then divided based on expression of F4/80 and Gr-1. (b) Quantification of the
proportion of bone marrow cells expressing HO-1, overall and in each quadrant (Q1-4)
based on F4/80 and Gr-1 expression in (a), for control PBS-treated, Py17XNL-infected (day
14), PHZ- and hemin-treated mice (18 h after treatment). Data representative of 2
independent experiments (mean ± s.d of 3-5 mice) per condition. (c) Flow cytometry
analysis showing identification of granulocyte macrophage progenitor (GMP) cells as
lineage− c-Kit+ Sca-1− FcγR+CD34+IL-7Ra−, and normalized HO-1 expression in GMP
cells determined by the ratio of the MFI of the fluorescence for the antibody against HO-1 to
control antibody staining for the same sample, normalized against the average expression in
PBS-treated mice in the same experiment (lower left panel). The IL7-Ra+ population
(shaded, lower right plot) is drawn from the LineageHi population in the upper, second left
plot. Data from 2 independent experiments, (mean ± s.d.) 4-8 mice per condition.
Significance was determined by one-way ANOVA with post-hoc comparison with control
condition using Dunnett’s multiple comparison test. *P < 0.05,**P < 0.01, ***P < 0.001.
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Figure 5. Impaired resistance to S. typhimurium is abrogated by inhbition of heme oxygenase
(a) S. typhimurium bacterial loads in blood, spleen and liver, of mice treated and harvested
as in Fig. 1e, with additional groups receiving SnPP or CoPP treatment. (b) Parasitemia of
SnPP-treated and untreated Py17XNL-infected mice immediately before treatment with
SnPP, immediately before infection with S. typhimurium, and 18 h after infection. (c)
Representative flow cytometry analysis of blood leukocytes from S. typhimurium -infected
mice treated as in Fig. 5a. (d) Quantification of GFP+ granulocytes as a proportion of all
granulocytes in blood. (e) Survival (to the humane endpoint) 18 h or 16 h after S.
typhimurium infection in Py17XNL-infected and PHZ-treated mice respectively, with or
without SnPP treatment. (a-e) Data represent pooled results (mean ± s.d) of 2 independent
experiments (6-9 mice per condition). (f) The oxidative burst of Gr-1Hi bone marrow
granulocytes (as in Fig. 3g). (g) Proportion of bone marrow cells that are Gr-1Hi following
SnPP treatment, expressed as a percentage of the average proportion of Gr-1Hi cells in the
equivalent treatment condition without SnPP. (h) Proportion of Gr-1Hi cells responding to
PMA with a low-level oxidative burst (as in Fig. 3h). Data representative of 2 independent
experiments (mean ± s.d of 3-5 mice) per condition. Significance determined by one-way
ANOVA with post-hoc comparisons using Dunnett’s multiple comparison test or
Bonferroni’s multiple comparison (bracketed groups) (a,b,d,f,h), Student’s t-test (g) and
Fisher’s exact test (e). *P < 0.05,**P < 0.01, ***P < 0.001.
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Figure 6. Proposed mechanism to explain how hemolysis impairs resistance to S. typhimurium
through heme- and heme oxygenase-dependent dysfunctional granulocyte mobilization
Proposed scheme for (a) granulocyte mobilization in response to S. typhimurium infection
and (b) the dysfunctional mobilization induced by hemolysis which causes (c) impaired
resistance to S. typhimurium. In normal C57BL/6 mice (a), S. typhimurium infection causes
emergency granulopoiesis (1) and mobilization of granulocytes from bone marrow (2).
These granulocytes are able to phagocytose S. typhimurium and generate a normal oxidative
burst, controlling bacterial replication (3). Intravascular hemolysis caused by malaria or
phenyhydrazine treatment liberates hemoglobin and hemoglobin-derived heme (b). Heme
induces heme oxygenase-1 (HO-1) in immature myeloid cells (4), and heme is degraded to
biliverdin, carbon monoxide and iron (magnified box). These heme degradation products
may modify the function of developing granulocytes. Heme also causes mobilization of
mature granulocytes from bone marrow (5), and may activate the oxidative burst (6).
However, in chronic hemolysis (as in the case of Py17XNL infection), functionally
immature granulocytes accumulate in the blood, ultimately resulting in reduced oxidative
burst capacity (7). The combination of hemolysis and S. typhimurium challenge (c),
increases mobilization of bone marrow granulocytes with reduced oxidative burst capacity
and increased cellular iron stores into the blood. These granulocytes are able to phagocytose
S. typhimurium normally, but are unable to kill the bacteria due to reduced oxidative burst
capacity, and support bacterial growth due increased iron availability, ultimately allowing
increased bacterial replication and dissemination (8).
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